Loading
Latest filing published 12 Dec 2023 for Nu-Med Plus, Inc., €3,544.
No signal scores available.
Only one filing by Jeffrey Lynn Robins is known so far (12 December 2023): a share grant, €3,544, in Nu-Med Plus, Inc. That is too little to draw conclusions. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration